Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2002

View Archived Issues

New data on the antioxidant capacity of phytochemicals

Daiichi updates status of quinolone antibacterial agents

Rights to angiotensin II receptor blocker for glaucoma licensed to Santen

Pioglitazone normalizes increased retinal leukocyte entrapment in diabetes

Cannabinoid agonist reduces IOP by decreasing aqueous humor flow

PKC-beta inhibition as an approach to the treatment of diabetic macular edema

Adenoviral gene transfer of PEDF inhibits choroidal neovascularization in animal models

CRF antagonists may be useful in the treatment of anxiety and affective disorders

Possible beneficial effects of GABA uptake inhibition on micturition

The health benefits of cranberries

Potent inhibitors of bacterial methionyl-tRNA synthetase active against Gram-positive pathogens

Immusol and Vertex collaborate on discovery of inflammation targets

Applied Molecular Evolution and Centocor sign antibody therapeutic optimization agreement

Design and SAR of new dual H1/H3 antagonists reported at ACS meeting

Kosan awarded SBIR grant for epothilone analogues

Ilex and Abgenix collaborate to develop antibody therapy for cancer

G-207 designated orphan drug in malignant glioma

Amgen acquires filgrastim and pegfilgrastim in Europe from Roche

IND approved for clinical trials of buccal morphine

FDA requests Provenge composition information from Dendreon

Dual CCR3 modulators/H1 antagonists designed at AstraZeneca

Roche patents new series of lanosterol synthase inhibitors

Trk tyrosine kinase inhibitors useful for cancer and pain according to GSK patent

Recent Chiron patent covers new pyridine and pyrimidine GSK3 inhibitors

New analgesics in the Gruenenthal pipeline

Uroselective alpha1-adrenoceptor blockers designed at Recordati

Inhibitors of cyclin-dependent kinases useful as antitumor agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...